- Home
- ROIV vs BROS Comparison
ROIV vs BROS Comparison
Compare ROIV & BROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- BROS
- Stock Information
- Founded
- ROIV 2014
- BROS 1992
- Country
- ROIV United Kingdom
- BROS United States
- Employees
- ROIV N/A
- BROS N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- BROS Restaurants
- Sector
- ROIV Health Care
- BROS Consumer Discretionary
- Exchange
- ROIV Nasdaq
- BROS Nasdaq
- Market Cap
- ROIV 8.6B
- BROS 9.1B
- IPO Year
- ROIV N/A
- BROS 2021
- Fundamental
- Price
- ROIV $14.08
- BROS $64.59
- Analyst Decision
- ROIV Strong Buy
- BROS Strong Buy
- Analyst Count
- ROIV 4
- BROS 18
- Target Price
- ROIV $15.50
- BROS $81.00
- AVG Volume (30 Days)
- ROIV 6.6M
- BROS 3.4M
- Earning Date
- ROIV 11-11-2025
- BROS 11-05-2025
- Dividend Yield
- ROIV N/A
- BROS N/A
- EPS Growth
- ROIV N/A
- BROS 75.89
- EPS
- ROIV N/A
- BROS 0.48
- Revenue
- ROIV $23,233,000.00
- BROS $1,451,963,000.00
- Revenue This Year
- ROIV N/A
- BROS $27.79
- Revenue Next Year
- ROIV $281.14
- BROS $24.80
- P/E Ratio
- ROIV N/A
- BROS $134.69
- Revenue Growth
- ROIV N/A
- BROS 29.80
- 52 Week Low
- ROIV $8.73
- BROS $30.49
- 52 Week High
- ROIV $14.48
- BROS $86.88
- Technical
- Relative Strength Index (RSI)
- ROIV 76.40
- BROS 45.42
- Support Level
- ROIV $11.85
- BROS $63.67
- Resistance Level
- ROIV $14.48
- BROS $66.77
- Average True Range (ATR)
- ROIV 0.42
- BROS 3.04
- MACD
- ROIV 0.21
- BROS -0.77
- Stochastic Oscillator
- ROIV 86.26
- BROS 8.38
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About BROS Dutch Bros Inc.
Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies and other beverages. The company has two reportable operating segments Company-operated shops and Franchising. It derives maximum revenue from Company operated shops.